By John Smith • 10 April 2020 • 14:39
SANOFI a French pharmaceutical company which manufactures Plaquenil, a drug based on hydroxychloroquine, which is being tested to see whether it can counter the effects of Covid-19 will send a quantity to Spain.
It has doubled its production and will be distributing 100 million doses to 50 different countries and will continue with increased manufacture if clinical studies indicate that it is effective against the virus.
The World Health Organisation has included the anti-malarial drug (which also helps those suffering from rheumatoid arthritis) in its recommended list of priority experimental treatment and it is reported that Spanish laboratories have recently initiated testing.
This is the drug that President Trump has said will cure the world but as yet there is no hard data to confirm that it is the miracle panacea that he has been promoting with the phrase “what do you have to lose?”
With manufacturing facilities all over the world, including the USA and much of Europe, the company is in a position to distribute the drug quickly and efficiently.
Share this story
Subscribe to our Euro Weekly News alerts to get the latest stories into your inbox!
By signing up, you will create a Euro Weekly News account if you don’t already have one. Review our
Married to Ophelia in Gibraltar in 1978, John has spent much of his life travelling on security print and minting business and visited every continent except Antarctica.
Having retired several years ago, the couple moved to their house in Estepona and John became a regular news writer for the EWN Media Group taking particular interest in Finance, Gibraltar and Costa del Sol Social Scene.
Share your story with us by emailing [email protected], by calling +34 951 38 61 61 or by messaging our Facebook page www.facebook.com/EuroWeeklyNews
Your email address will not be published. Required fields are marked *
Download our media pack in either English or Spanish.